C W Hanson

856 total citations
20 papers, 708 citations indexed

About

C W Hanson is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, C W Hanson has authored 20 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 9 papers in Molecular Medicine and 7 papers in Infectious Diseases. Recurrent topics in C W Hanson's work include Antibiotic Resistance in Bacteria (9 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Bacterial Identification and Susceptibility Testing (5 papers). C W Hanson is often cited by papers focused on Antibiotic Resistance in Bacteria (9 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Bacterial Identification and Susceptibility Testing (5 papers). C W Hanson collaborates with scholars based in United States, United Kingdom and Czechia. C W Hanson's co-authors include Prabhavathi Fernandes, Dwight J. Hardy, R. N. Swanson, N Ramer, N. L. Shipkowitz, Dennis P. McDaniel, Robert R. Bower, William Martin, D. T. W. CHU and Robert T. Bailer and has published in prestigious journals such as Journal of Bacteriology, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

C W Hanson

20 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C W Hanson United States 14 316 265 257 205 189 20 708
N. L. Shipkowitz United States 19 484 1.5× 239 0.9× 239 0.9× 173 0.8× 244 1.3× 29 1.0k
B Slocombe United Kingdom 13 198 0.6× 314 1.2× 252 1.0× 264 1.3× 322 1.7× 31 870
D Girard United States 16 430 1.4× 274 1.0× 376 1.5× 248 1.2× 141 0.7× 29 1.0k
P. Acred United Kingdom 14 160 0.5× 145 0.5× 311 1.2× 236 1.2× 136 0.7× 30 675
A Buré France 14 312 1.0× 270 1.0× 249 1.0× 433 2.1× 140 0.7× 45 884
Beatrice Minassian United States 14 323 1.0× 330 1.2× 284 1.1× 203 1.0× 142 0.8× 18 783
E. L. Moss United States 15 190 0.6× 193 0.7× 233 0.9× 180 0.9× 139 0.7× 28 649
E Huczko United States 15 356 1.1× 317 1.2× 345 1.3× 273 1.3× 114 0.6× 20 806
Dena M. Hensey United States 9 239 0.8× 126 0.5× 233 0.9× 141 0.7× 140 0.7× 9 574
B Kolek United States 13 206 0.7× 173 0.7× 307 1.2× 294 1.4× 151 0.8× 16 637

Countries citing papers authored by C W Hanson

Since Specialization
Citations

This map shows the geographic impact of C W Hanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C W Hanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C W Hanson more than expected).

Fields of papers citing papers by C W Hanson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C W Hanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C W Hanson. The network helps show where C W Hanson may publish in the future.

Co-authorship network of co-authors of C W Hanson

This figure shows the co-authorship network connecting the top 25 collaborators of C W Hanson. A scholar is included among the top collaborators of C W Hanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C W Hanson. C W Hanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Swanson, R. N., Dwight J. Hardy, N. L. Shipkowitz, et al.. (1991). In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile. Antimicrobial Agents and Chemotherapy. 35(6). 1108–1111. 75 indexed citations
3.
Fernandes, Prabhavathi, et al.. (1989). Coumamidines, new broad spectrum antibiotics of the cinodine type. III. Microbiologic activity of coumamidine .GAMMA.1.. The Journal of Antibiotics. 42(4). 538–541. 5 indexed citations
4.
Swanson, R. N., Dwight J. Hardy, N. L. Shipkowitz, et al.. (1989). Phenelfamycins, a novel complex of elfamycin-type antibiotics. III. Activity in vitro and in a hamster colitis model.. The Journal of Antibiotics. 42(1). 94–101. 5 indexed citations
5.
Fernandes, Prabhavathi, Dwight J. Hardy, Dennis P. McDaniel, C W Hanson, & R. N. Swanson. (1989). In vitro and in vivo activities of clarithromycin against Mycobacterium avium. Antimicrobial Agents and Chemotherapy. 33(9). 1531–1534. 140 indexed citations
6.
Fernandes, Prabhavathi, et al.. (1989). Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. III. Microbiologic profile.. The Journal of Antibiotics. 42(4). 521–526. 51 indexed citations
7.
Fernandes, Prabhavathi, D. T. W. CHU, R. N. Swanson, et al.. (1988). A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria. Antimicrobial Agents and Chemotherapy. 32(1). 27–32. 26 indexed citations
8.
Hardy, Dwight J., R. N. Swanson, Dena M. Hensey, et al.. (1987). Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones. Antimicrobial Agents and Chemotherapy. 31(11). 1768–1774. 96 indexed citations
9.
Hanson, C W, et al.. (1987). Regression analysis, proposed interpretative zone size standards, and quality control guidelines for a new macrolide antimicrobial agent, A-56268 (TE-031). Journal of Clinical Microbiology. 25(6). 1079–1082. 13 indexed citations
10.
Fernandes, Prabhavathi, et al.. (1987). The frequency of in-vitro resistance development to fluoroquinolones and the use of a murine pyelonephritis model to demonstrate selection of resistance in vivo. Journal of Antimicrobial Chemotherapy. 19(4). 449–465. 32 indexed citations
11.
Stamm, John M., et al.. (1986). In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones. Antimicrobial Agents and Chemotherapy. 29(2). 193–200. 48 indexed citations
12.
Fernandes, Prabhavathi, Robert T. Bailer, R. N. Swanson, et al.. (1986). In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. Antimicrobial Agents and Chemotherapy. 30(6). 865–873. 126 indexed citations
13.
Hanson, C W, et al.. (1981). DOMSAT OPERATIONS SUPPORT WITH A SINGLE COMPUTER. UA Campus Repository (The University of Arizona). 1 indexed citations
14.
Hanson, C W & William J. Martin. (1980). Antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens by using an agar dilution procedure. Current Microbiology. 3(6). 349–353. 13 indexed citations
15.
Hanson, C W, et al.. (1979). API and Minitek systems in identification of clinical isolates of anaerobic gram-negative bacilli and Clostridium species. Journal of Clinical Microbiology. 10(1). 14–18. 25 indexed citations
16.
Hanson, C W & William Martin. (1978). Modified agar dilution method for rapid antibiotic susceptibility testing of anaerobic bacteria. Antimicrobial Agents and Chemotherapy. 13(3). 383–388. 13 indexed citations
17.
Hanson, C W & William Martin. (1978). Microwave Oven for Melting Laboratory Media. Journal of Clinical Microbiology. 7(4). 401–402. 5 indexed citations
18.
Hanson, C W & William Martin. (1976). Evaluation of enrichment, storage, and age of blood agar medium in relation to its ability to support growth of anaerobic bacteria. Journal of Clinical Microbiology. 4(5). 394–399. 18 indexed citations
19.
Hanson, C W & Martin Dworkin. (1974). Intracellular and Extracellular Nucleotides and Related Compounds During the Development of Myxococcus xanthus. Journal of Bacteriology. 118(2). 486–496. 13 indexed citations
20.
Hanson, C W, et al.. (1973). Some aspects of amino acid metabolism in the fruiting myxobacterium, Myxococcus xanthus. Archives of Microbiology. 92(1). 1–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. L. Shipkowitz Breakdown of academic impact, for papers by B Slocombe Breakdown of academic impact, for papers by D Girard Breakdown of academic impact, for papers by P. Acred Breakdown of academic impact, for papers by A Buré Breakdown of academic impact, for papers by Beatrice Minassian Breakdown of academic impact, for papers by E. L. Moss Breakdown of academic impact, for papers by E Huczko Breakdown of academic impact, for papers by Dena M. Hensey Breakdown of academic impact, for papers by B Kolek
Rankless by CCL
2026